BURCON NUTRASCIENCE CORP (BRCN) Stock Price & Overview

NASDAQ:BRCNCA1208311029

Current stock price

0.44 USD
-0.02 (-4.78%)
At close:
0.44 USD
0 (0%)
After Hours:

The current stock price of BRCN is 0.44 USD. Today BRCN is down by -4.78%. In the past month the price decreased by -36.23%. In the past year, price decreased by -80.87%.

BRCN Key Statistics

52-Week Range0.35 - 2.36
Current BRCN stock price positioned within its 52-week range.
1-Month Range0.43 - 0.7164
Current BRCN stock price positioned within its 1-month range.
Market Cap
47.841M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-0.07
Dividend Yield
N/A

BRCN Stock Performance

Today
-4.78%
1 Week
-15.64%
1 Month
-36.23%
3 Months
-21.78%
Longer-term
6 Months -42.86%
1 Year -80.87%
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A

BRCN Stock Chart

BURCON NUTRASCIENCE CORP / BRCN Daily stock chart

BRCN Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to BRCN. When comparing the yearly performance of all stocks, BRCN is a bad performer in the overall market: 93.25% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

BRCN Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to BRCN. While BRCN has a great health rating, there are worries on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

BRCN Earnings

Next Earnings DateNov 14, 2022
Last Earnings DateAug 15, 2022
PeriodQ1 / 2023
EPS Reported-CA$0.04
Revenue Reported
EPS Surprise %
Revenue Surprise %

BRCN Forecast & Estimates

11 analysts have analysed BRCN and the average price target is 1.67 USD. This implies a price increase of 279.09% is expected in the next year compared to the current price of 0.44.

For the next year, analysts expect an EPS growth of -26.67% and a revenue growth 489.89% for BRCN


Analysts
Analysts85.45
Price Target1.67 (279.55%)
EPS Next Y-26.67%
Revenue Next Year489.89%

BRCN Groups

Sector & Classification

Index Membership

BRCN Financial Highlights

Over the last trailing twelve months BRCN reported a non-GAAP Earnings per Share(EPS) of -0.07. The EPS decreased by -416.56% compared to the year before.


Income Statements
Revenue(TTM)244.05K
Net Income(TTM)-11.07M
Industry RankSector Rank
PM (TTM) -4537.09%
ROA -43.62%
ROE N/A
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-25.29%
Sales Q2Q%403.84%
EPS 1Y (TTM)-416.56%
Revenue 1Y (TTM)-8.93%

BRCN Ownership

Ownership
Inst Owners6.93%
Shares108.73M
Float77.36M
Ins OwnersN/A
Short Float %N/A
Short RatioN/A

About BRCN

Company Profile

BRCN logo image Burcon NutraScience Corp. engages in the development of plant proteins and ingredients for use in the food and beverage industries in Canada. The company is headquartered in Vancouver, British Columbia and currently employs 19 full-time employees. The firm is engaged in development of plant protein extraction and purification technology in the field of functional, renewable plant proteins. The firm has a portfolio of composition, application and process patents covering plant-based proteins derived from pea, canola, soy, hemp and sunflower seeds. The firm has developed pea proteins that it has branded Peazazz and Peazac, and over three canola protein products, Puratein, Supertein and Nutratein. The firm also includes CLARISOY, which is a soy protein. The Company’s subsidiaries include Burcon NutraScience (MB) Corp. and Burcon NutraScience Holdings Corp.

Company Info

IPO: 1999-02-19

BURCON NUTRASCIENCE CORP

1946 Broadway W

Vancouver BRITISH COLUMBIA CA

CEO: Johann Franz Tergesen

Employees: 19

BRCN Company Website

Phone: 16047330896.0

BURCON NUTRASCIENCE CORP / BRCN FAQ

What does BRCN do?

Burcon NutraScience Corp. engages in the development of plant proteins and ingredients for use in the food and beverage industries in Canada. The company is headquartered in Vancouver, British Columbia and currently employs 19 full-time employees. The firm is engaged in development of plant protein extraction and purification technology in the field of functional, renewable plant proteins. The firm has a portfolio of composition, application and process patents covering plant-based proteins derived from pea, canola, soy, hemp and sunflower seeds. The firm has developed pea proteins that it has branded Peazazz and Peazac, and over three canola protein products, Puratein, Supertein and Nutratein. The firm also includes CLARISOY, which is a soy protein. The Company’s subsidiaries include Burcon NutraScience (MB) Corp. and Burcon NutraScience Holdings Corp.


Can you provide the latest stock price for BURCON NUTRASCIENCE CORP?

The current stock price of BRCN is 0.44 USD. The price decreased by -4.78% in the last trading session.


Does BRCN stock pay dividends?

BRCN does not pay a dividend.


What is the ChartMill technical and fundamental rating of BRCN stock?

BRCN has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 4 out of 10.


Can you provide the market cap for BURCON NUTRASCIENCE CORP?

BURCON NUTRASCIENCE CORP (BRCN) has a market capitalization of 47.84M USD. This makes BRCN a Nano Cap stock.


Can you provide the ownership details for BRCN stock?

You can find the ownership structure of BURCON NUTRASCIENCE CORP (BRCN) on the Ownership tab.